Patent Application: Treating Blood Clots with Nerve Stimulation

ChangeBridge: Patent Apps - Health Informatics (G16H)

Detected March 26th, 2026

Summary

The USPTO has published a patent application from ElectroCore, Inc. detailing systems and methods for treating blood clots using nerve stimulation, particularly for post-COVID conditions. The application describes transcutaneous electrical impulses to a vagus nerve branch to reduce antibodies associated with blood clotting.

View original document View source feed page

What changed

This document is a published patent application (US20260088185A1) from ElectroCore, Inc. It describes a novel method for treating blood clots, specifically those associated with replicating pathogens like viruses (e.g., coronaviridae family), by applying transcutaneous electrical impulses to a cervical branch of the vagus nerve. The goal is to reduce antibodies linked to blood clotting, with a particular focus on treating post-COVID conditions.

As this is a patent application, it does not impose direct regulatory obligations on entities. However, it signals potential future developments in medical treatments for conditions like long COVID. Companies involved in medical devices, pharmaceuticals, or healthcare services, particularly those focused on neurological or infectious disease treatments, should be aware of this technological advancement for competitive intelligence and potential licensing opportunities.

Source document (simplified)

← USPTO Patent Applications

SYSTEMS AND METHODS FOR TREATING BLOOD CLOTS WITH NERVE STIMULATION

Application US20260088185A1 Kind: A1 Mar 26, 2026

Assignee

ElectroCore, Inc.

Inventors

Joseph P. Errico, Bruce J. Simon, Peter Staats, Thomas Errico

Abstract

Systems and methods are provided for treating blood clots associated with a replicating pathogen, such as a virus in the coronaviridae family. The systems and methods include applying an electrical impulse transcutaneously through the outer skin surface of the patient to a cervical branch of the vagus nerve of the patient. The electrical impulse is sufficient to reduce a number of antibodies associated with blood clotting to reduce a level of blood clotting in the patient. The systems and methods are particularly useful for treating post-COVID conditions or post-acute sequelae of COVID-19 that develop in “long-haul” or COVID patients.